World’s First CAR-T Therapy for Solid Tumors Available in China Soon
A New Hope for Patients with Advanced Gastric and Pancreatic Cancers SHANGHAI, April 9, 2026 /PRNewswire/ -- A groundbreaking new CAR-T cell therapy for advanced gastrointestinal cancers is expected to become available in China in the first half of 2026, marking a major step forward in cancer treatment. Jiahui International Cancer Center will be among the leading medical institutions...
NSG Bio and Charles River Sign Memorandum of Understanding to Strengthen Support for Biotech Innovation in Singapore
Partnership to expand ecosystem connectivity, expertise access, and enablement for life sciences companies SINGAPORE, April 9, 2026 /PRNewswire/ -- NSG Bio announced the signing of a Memorandum of Understanding (MOU) with Charles River Laboratories ("Charles River"), marking a new collaboration aimed at strengthening support for biotech companies building and scaling in...
Shaklee Announces Appointment of New General Manager for Australia and New Zealand
MIAMI, April 9, 2026 /PRNewswire/ -- Shaklee, a global leader in health and wellness, announced the appointment of Bianca Cosentino as General Manager of Shaklee Australia and New Zealand, effective March 26th, 2026. Bianca brings nearly 20 years of leadership experience in the direct selling and wellness industries with a proven track record of driving sustainable growth...
Telix Strengthens Board with Additional Director Appointments
MELBOURNE, Australia and INDIANAPOLIS, April 9, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces two additional Non-Executive Director (NED) appointments, effective May 11, 2026, as part of Board expansion and succession planning:
Maria Rivas, MD is an experienced public company board director and S&P...
Big Tree Cloud Holdings Limited Announces Transfer of Listing to Nasdaq Capital Market
SHENZHEN, China, April 9, 2026 /PRNewswire/ -- Big Tree Cloud Holdings Limited (the "Company") (NASDAQ: DSY) today announced that on April 7, 2026, it received approval from The Nasdaq Stock Market LLC ("Nasdaq") to transfer the listing of its Class A Ordinary Shares from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer will become effective at the...
First Implant of KingstronBio’s ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Study
SHANGHAI, April 8, 2026 /PRNewswire/ -- On March 12, 2026, the first implant of the ProStyle M® Transcatheter Mitral Valve System (ProStyle M®) was successfully completed under pure ultrasound guidance as part of its confirmatory clinical study. The device is independently developed by KingstronBio Technology (Changshu) Co., Ltd. (KingstronBio). The procedure was performed by Professor Wang Chunsheng and Professor Wei...
MALAYSIA HEALTHCARE WEEK KICKS OFF IN DHAKA AS BANGLADESH’S PATIENT MARKET SHIFTS
DHAKA, Bangladesh, April 8, 2026 /PRNewswire/ -- Malaysia Healthcare Week in Dhaka 2026 has officially commenced, bringing Malaysia's healthcare expertise directly to Bangladeshi patients, partners and industry stakeholders as demand for overseas medical treatment continues to rise across the country. Organised by the Malaysia Healthcare...
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors
Milestones underscore clinical progress and strengthen commercial foundation LOS GATOS, Calif., April 8, 2026 /PRNewswire/ -- Supira Medical, Inc. (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assist device (pVAD) market, today announced FDA approval to initiate the SUPPORT II Pivotal Trial. The trial is designed to support a future PMA...
Portrai to Present 11 Posters on AI-Driven Spatial Transcriptomics at AACR 2026
The South Korean spatial biology company unveils new AI agents, foundation models, and spatial biomarkers for oncology drug discovery. SEOUL, South Korea, April 8, 2026 /PRNewswire/ -- Portrai, Inc. today announced it will present 11 posters highlighting its artificial intelligence and spatial transcriptomics capabilities at the American Association for Cancer Research...
“Lactobacillus Rhamnosus L34”: A Native Probiotic That Reduces Inflammation in Patients with Chronic Kidney Disease
BANGKOK, April 8, 2026 /PRNewswire/ -- Researchers from the Faculty of Medicine at Chulalongkorn University have identified a native probiotic strain, Lactobacillus rhamnosus L34, that may help reduce inflammation and toxin buildup in patients with chronic kidney disease (CKD) before dialysis. The discovery highlights the growing role of microbiome-based therapies in managing chronic diseases and has led to the development...
